Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer

  1. Rudin, C.M.
  2. Cervantes, A.
  3. Dowlati, A.
  4. Besse, B.
  5. Ma, B.
  6. Costa, D.B.
  7. Schmid, P.
  8. Heist, R.
  9. Villaflor, V.M.
  10. Spahn, J.
  11. Li, S.
  12. Cha, E.
  13. Riely, G.J.
  14. Gettinger, S.
Aldizkaria:
ESMO Open

ISSN: 2059-7029

Argitalpen urtea: 2023

Alea: 8

Zenbakia: 2

Mota: Artikulua

DOI: 10.1016/J.ESMOOP.2023.101160 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus